GCGen Chen

Gen Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gen Chen has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Zhen Li

    Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

    2 shared publications
  • Baodi Deng

    Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

    1 shared publication
  • Daoyu Hu

    Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China

    1 shared publication
  • Hao Tang

    Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

    1 shared publication
  • Hui Guo

    Institute of Organ Transplantation, Key Laboratory of Organ Transplantation, Ministry of Education NHC Key Laboratory of Organ Transplantation, Key Laboratory of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Chinese Academy of Medical Sciences, Wuhan, People’s Republic of China

    1 shared publication
  • Ihab R. Kamel

    Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins Medical Institutions, Baltimore, USA

    1 shared publication

Latest Publications

  • Open Access

    Navigating the diagnostic ‘gray zone’: prospective evaluation of an integrated MRI-Biomarker model for renal allograft triage

    by Zhouyan Liao, Siyuan Ma, Ziyi Liu, Hao Tang, Baodi Deng, Jie Zhang, Ting Yin, Wei Chen, Omar Darwish, Qiuxia Wang, et al.

    A critical dilemma in post-transplant surveillance is determining when minor functional changes (subtle serum creatinine fluctuations or slow renal function decline) or ambiguous ultrasound findings (including mildly elevated resistive index or cortical echogenicity) warrant invasive biopsy and treatment modification. We aimed to develop a non-invasive integrated tool combining advanced diffusion MRI with functional biomarkers to stratify patients within this diagnostic gray zone. In this prospective study, 120 renal transplant recipients underwent multi-b-value diffusion-weighted imaging at 3.0 T within 48 h prior to an allograft biopsy. Quantitative parameters of six diffusion MRI models were extracted from renal cortex and medulla. Clinical indicators, including serum HCO3-, were recorded. To establish a clear endpoint, patients were categorized into a Treatment-Changed group (presence of actionable active pathology, requiring modified therapies) and a Treatment-Unchanged group (normal or solely chronic/non-reversible lesions). Multivariable logistic regression identified independent predictors. Diagnostic performance was assessed using area under the curve (AUC) using repeated stratified 5-fold cross validation with 10 repeats and bootstrap resampling. Kaplan–Meier analysis assessed the association between model-based risk and subsequent graft functional decline, defined as a 30% or greater decrease in estimated glomerular filtration rate (eGFR) from baseline. The cortical distributed diffusion coefficient (DDC) and serum HCO3-, emerged as independent predictors of treatment-changed group. The integrated model achieved an AUC of 0.941, significantly outperforming the standard clinical reference model (eGFR, proteinuria, and ultrasound; AUC 0.563). Net reclassification improvement (0.479) demonstrated the model correctly reclassified 45.6% of patients. Furthermore, model-derived high-risk status significantly predicted long-term graft functional decline (log-rank p = 0.005). This integrated multiparametric protocol provides promising preliminary decision support for renal allograft surveillance. By noninvasively identifying the potential presence of actionable active pathology, this preliminary model may help optimize biopsy referrals and stratify patients who potentially require treatment modification. However, given the single-centre design, external validation is required before clinical implementation.

  • Quantitative MRI of liver grafts for assessment of macrovesicular steatosis ex vivo and long-term follow-up outcomes

    by Gen Chen, Jipin Jiang, Xinqiang Wang, Hui Guo, Lifen Zhou, Daoyu Hu, Ihab R. Kamel, Zhishui Chen, Zhen Li